142,951 members

Skip to content. | Skip to navigation

DMID 11.0069 Valgan Toddler Study

Welcome to the DMID 11.0069 Valgan Toddler Trial

Network navigation
 

Welcome to the DMID 11.0069 Valgan Toddler Trial

Congenital CMV and Hearing Loss A Phase II study of 6 Weeks Oral Valganciclovir Therapy in Children with Congenital Cytomegalovirus Infection and SensoriNeural Hearing Loss

This website is currently being updated.

Recruitment closes mid July 2019.

https://clinicaltrials.gov/ct2/show/NCT01649869?term=11-0069&rank=1 

At the end of the trial the results will be published.